These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 943132)

  • 21. Effect of intravenous injection of stypven or thrombin on coagulation and fibrinolysis of blood and lymph in dogs.
    Leandoer L; Niléhn JE
    Acta Chir Scand; 1969; 135(1):7-13. PubMed ID: 5805947
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of severe intermittent claudication by controlled defibrination.
    Dormandy JA; Goyle KB; Reid HL
    Lancet; 1977 Mar; 1(8012):625-6. PubMed ID: 66429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of fibrinogen synthesis by thrombin in rabbits with ancrod-induced afibrinogenemia.
    Alving BM; Evatt BL; Bell WR
    Am J Physiol; 1977 Nov; 233(5):562-7. PubMed ID: 920833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparable studies of the behaviour of the plasmic coagulation, the fibrinolysis as well as the platelets under application of dextran or hydroxyethyl-starch (HES).
    Popov-Cenić S; Müller N; Kladetzky RG; Hack G; Lang U
    Bibl Anat; 1977; (16 Pt 2):322-5. PubMed ID: 75005
    [No Abstract]   [Full Text] [Related]  

  • 25. Toxicologically relevant disturbances of haemostasis.
    Klöcking HP
    Arch Toxicol Suppl; 1985; 8():142-7. PubMed ID: 3868342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relations between the concentration of fibrinogen, thromboplastin time, thrombin time and reptilase time in patients treated with Arwin].
    Paar D; Klüken N
    Med Welt; 1975 Sep; 26(38):1700-1. PubMed ID: 1186461
    [No Abstract]   [Full Text] [Related]  

  • 27. Arwin in peripheral arterial circulatory disorders: controlled multicentre trials.
    Wolf GK
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):387-92. PubMed ID: 786664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the platelet aggregation induced by three thrombin-like enzymes of snake venoms and thrombin.
    Teng CM; Ko FN
    Thromb Haemost; 1988 Apr; 59(2):304-9. PubMed ID: 3291184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombocytopenia in defibrination syndrom induced by Echis carinatus venom coagulase.
    Kornalík F; Fortýnová J; Táborská E; Táborská Z; Hlavatá O
    Acta Univ Carol Med Monogr; 1972; 53():433-9. PubMed ID: 4670751
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of some antibiotics of platelet function in vitro and in vivo.
    Johnsson H; Niklasson PM
    Thromb Res; 1977 Aug; 11(2):237-51. PubMed ID: 905975
    [No Abstract]   [Full Text] [Related]  

  • 31. Possible pathway for formation of fibrin degradation products during ancrod therapy.
    McKillop C; Edgar W; Forbes CD; Prentice CR
    Nature; 1975 Jun; 255(5510):638-40. PubMed ID: 1134556
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparative effects of ancrod, urokinase and heparin on intraglomerular coagulation induced by progressive Masugi nephritis (author's transl)].
    Fujioka M
    Nihon Jinzo Gakkai Shi; 1980 Aug; 22(8):1113-24. PubMed ID: 7012408
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of the oral antidiabetic agent glibornuride on blood coagulation, blood platelets, and fibrinolysis].
    Voss D; Fuchs G; Schneider D; Schneider J
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2219. PubMed ID: 4679252
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of defibrinating agents ancrod and reptilase in the treatment of thromboembolism.
    Kwaan HC
    Thromb Diath Haemorrh Suppl; 1973; 56():239-51. PubMed ID: 4617331
    [No Abstract]   [Full Text] [Related]  

  • 35. Multiple courses of ancrod (Arvin) therapy.
    Br Med J; 1977 Feb; 1(6059):508-9. PubMed ID: 837184
    [No Abstract]   [Full Text] [Related]  

  • 36. [Aspects of defibrinogenation therapy].
    Klüken N
    Phlebologie; 1975; 28(1):39-41. PubMed ID: 1202532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [On some changes of coagulation, fibrinolysis and blood platelets in patients treated with indirect anticoagulants].
    Crolle G; Arturi F; Cerutti G; Del Piano GC; Garbero F
    G Gerontol; 1968 Mar; 17(1):47-57. PubMed ID: 5731484
    [No Abstract]   [Full Text] [Related]  

  • 38. A report on the use of Arvin in patients with pre-gangrene of the lower limb.
    Humphreys WV; Walker A; Charlesworth D
    Br J Surg; 1977 Jan; 64(1):31-3. PubMed ID: 831951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defibrination with ancrod in glomerulonephritis: effects on clinical and histologic findings and on blood coagulation.
    Pollak VE; Glueck HI; Weiss MA; Lebron-Berges A; Miller MA
    Am J Nephrol; 1982; 2(4):195-207. PubMed ID: 6816068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vitro effects of hemocoagulase atrix and its effective components on blood coagulation of patients with bleeding disorders].
    Wang RJ; Wang ZY; Jiang MH; Zhang W; Cao LJ; Sun XH; Zhang J; Bai X; Ruan CG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):376-80. PubMed ID: 22541102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.